Literature DB >> 33514726

Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas.

Xin Hu1, Marcos R Estecio2,3, Runzhe Chen4, Alexandre Reuben4, Linghua Wang1, Junya Fujimoto5, Jian Carrot-Zhang6,7,8, Nicholas McGranahan9, Lisha Ying10,11, Junya Fukuoka12, Chi-Wan Chow5, Hoa H N Pham12, Myrna C B Godoy13, Brett W Carter13, Carmen Behrens4,5, Jianhua Zhang1, Mara B Antonoff14, Boris Sepesi14, Yue Lu2,3, Harvey I Pass15, Humam Kadara5, Paul Scheet16, Ara A Vaporciyan14, John V Heymach4, Ignacio I Wistuba4,5, J Jack Lee17, P Andrew Futreal18, Dan Su19, Jean-Pierre J Issa20, Jianjun Zhang21,22.   

Abstract

The evolution of DNA methylome and methylation intra-tumor heterogeneity (ITH) during early carcinogenesis of lung adenocarcinoma has not been systematically studied. We perform reduced representation bisulfite sequencing of invasive lung adenocarcinoma and its precursors, atypical adenomatous hyperplasia, adenocarcinoma in situ and minimally invasive adenocarcinoma. We observe gradual increase of methylation aberrations and significantly higher level of methylation ITH in later-stage lesions. The phylogenetic patterns inferred from methylation aberrations resemble those based on somatic mutations suggesting parallel methylation and genetic evolution. De-convolution reveal higher ratio of T regulatory cells (Tregs) versus CD8 + T cells in later-stage diseases, implying progressive immunosuppression with neoplastic progression. Furthermore, increased global hypomethylation is associated with higher mutation burden, copy number variation burden and AI burden as well as higher Treg/CD8 ratio, highlighting the potential impact of methylation on chromosomal instability, mutagenesis and tumor immune microenvironment during early carcinogenesis of lung adenocarcinomas.

Entities:  

Year:  2021        PMID: 33514726     DOI: 10.1038/s41467-021-20907-z

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  59 in total

1.  Epigenetic stem cell signature in cancer.

Authors:  Martin Widschwendter; Heidi Fiegl; Daniel Egle; Elisabeth Mueller-Holzner; Gilbert Spizzo; Christian Marth; Daniel J Weisenberger; Mihaela Campan; Joanne Young; Ian Jacobs; Peter W Laird
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

Review 2.  The epigenomics of cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

Review 3.  Non-small-cell lung cancers: a heterogeneous set of diseases.

Authors:  Zhao Chen; Christine M Fillmore; Peter S Hammerman; Carla F Kim; Kwok-Kin Wong
Journal:  Nat Rev Cancer       Date:  2014-08       Impact factor: 60.716

Review 4.  IASLC/ATS/ERS International Multidisciplinary Classification of Lung Adenocarcinoma: novel concepts and radiologic implications.

Authors:  Hyun-Ju Lee; Chang Hun Lee; Yeon Joo Jeong; Doo Hyun Chung; Jin Mo Goo; Chang Min Park; John H M Austin
Journal:  J Thorac Imaging       Date:  2012-11       Impact factor: 3.000

5.  DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma.

Authors:  Suhaida A Selamat; Janice S Galler; Amit D Joshi; M Nicky Fyfe; Mihaela Campan; Kimberly D Siegmund; Keith M Kerr; Ite A Laird-Offringa
Journal:  PLoS One       Date:  2011-06-23       Impact factor: 3.240

Review 6.  The role of DNA methylation in the development and progression of lung adenocarcinoma.

Authors:  Keith M Kerr; Janice S Galler; Jeffrey A Hagen; Peter W Laird; Ite A Laird-Offringa
Journal:  Dis Markers       Date:  2007       Impact factor: 3.434

7.  Absolute quantification of somatic DNA alterations in human cancer.

Authors:  Scott L Carter; Kristian Cibulskis; Elena Helman; Aaron McKenna; Hui Shen; Travis Zack; Peter W Laird; Robert C Onofrio; Wendy Winckler; Barbara A Weir; Rameen Beroukhim; David Pellman; Douglas A Levine; Eric S Lander; Matthew Meyerson; Gad Getz
Journal:  Nat Biotechnol       Date:  2012-05       Impact factor: 54.908

Review 8.  New horizons in surgical treatment of ground-glass nodules of the lung: experience and controversies.

Authors:  Donglai Chen; Chenyang Dai; Xiermaimaiti Kadeer; Rui Mao; Yongbing Chen; Chang Chen
Journal:  Ther Clin Risk Manag       Date:  2018-01-31       Impact factor: 2.423

9.  DNA methylation intratumor heterogeneity in localized lung adenocarcinomas.

Authors:  Kelly Quek; Jun Li; Marcos Estecio; Jiexin Zhang; Junya Fujimoto; Emily Roarty; Latasha Little; Chi-Wan Chow; Xingzhi Song; Carmen Behrens; Taiping Chen; William N William; Stephen Swisher; John Heymach; Ignacio Wistuba; Jianhua Zhang; Andrew Futreal; Jianjun Zhang
Journal:  Oncotarget       Date:  2017-03-28

10.  Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma.

Authors:  Xin Hu; Junya Fujimoto; Lisha Ying; Ignacio I Wistuba; Waun Ki Hong; P Andrew Futreal; Dan Su; Jianjun Zhang; Junya Fukuoka; Kazuto Ashizawa; Wenyong Sun; Alexandre Reuben; Chi-Wan Chow; Nicholas McGranahan; Runzhe Chen; Jinlin Hu; Myrna C Godoy; Kazuhiro Tabata; Kishio Kuroda; Lei Shi; Jun Li; Carmen Behrens; Edwin Roger Parra; Latasha D Little; Curtis Gumbs; Xizeng Mao; Xingzhi Song; Samantha Tippen; Rebecca L Thornton; Humam Kadara; Paul Scheet; Emily Roarty; Edwin Justin Ostrin; Xu Wang; Brett W Carter; Mara B Antonoff; Jianhua Zhang; Ara A Vaporciyan; Harvey Pass; Stephen G Swisher; John V Heymach; J Jack Lee
Journal:  Nat Commun       Date:  2019-07-05       Impact factor: 14.919

View more
  7 in total

1.  Gut bacterial isoamylamine promotes age-related cognitive dysfunction by promoting microglial cell death.

Authors:  Yun Teng; Jingyao Mu; Fangyi Xu; Xiangcheng Zhang; Mukesh K Sriwastva; Qiaohong M Liu; Xiaohong Li; Chao Lei; Kumaran Sundaram; Xin Hu; Lifeng Zhang; Juw Won Park; Jae Yeon Hwang; Eric C Rouchka; Xiang Zhang; Jun Yan; Michael L Merchant; Huang-Ge Zhang
Journal:  Cell Host Microbe       Date:  2022-06-01       Impact factor: 31.316

2.  Soluble Immune Checkpoint-Related Proteins in Blood Are Associated With Invasion and Progression in Non-Small Cell Lung Cancer.

Authors:  Qinchuan Wang; Yue He; Wanlu Li; Xiaohang Xu; Qingfeng Hu; Zilong Bian; Andi Xu; Huakang Tu; Ming Wu; Xifeng Wu
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

3.  Immunogenomic intertumor heterogeneity across primary and metastatic sites in a patient with lung adenocarcinoma.

Authors:  Runzhe Chen; Jun Li; Junya Fujimoto; Lingzhi Hong; Xin Hu; Kelly Quek; Ming Tang; Akash Mitra; Carmen Behrens; Chi-Wan Chow; Peixin Jiang; Latasha D Little; Curtis Gumbs; Xingzhi Song; Jianhua Zhang; Dongfeng Tan; John V Heymach; Ignacio Wistuba; P Andrew Futreal; Don L Gibbons; Lauren A Byers; Jianjun Zhang; Alexandre Reuben
Journal:  J Exp Clin Cancer Res       Date:  2022-05-11

4.  Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features.

Authors:  Hitoshi Dejima; Xin Hu; Runzhe Chen; Jiexin Zhang; Junya Fujimoto; Edwin R Parra; Cara Haymaker; Shawna M Hubert; Dzifa Duose; Luisa M Solis; Dan Su; Junya Fukuoka; Kazuhiro Tabata; Hoa H N Pham; Nicholas Mcgranahan; Baili Zhang; Jie Ye; Lisha Ying; Latasha Little; Curtis Gumbs; Chi-Wan Chow; Marcos Roberto Estecio; Myrna C B Godoy; Mara B Antonoff; Boris Sepesi; Harvey I Pass; Carmen Behrens; Jianhua Zhang; Ara A Vaporciyan; John V Heymach; Paul Scheet; J Jack Lee; Jia Wu; P Andrew Futreal; Alexandre Reuben; Humam Kadara; Ignacio I Wistuba; Jianjun Zhang
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 14.919

5.  Multiomics Analysis Reveals Distinct Immunogenomic Features of Lung Cancer with Ground-Glass Opacity.

Authors:  Kezhong Chen; Jing Bai; Alexandre Reuben; Heng Zhao; Guannan Kang; Chunliu Zhang; Qingyi Qi; Yaping Xu; Shawna Hubert; Lianpeng Chang; Yanfang Guan; Lin Feng; Kai Zhang; Kaitai Zhang; Xin Yi; Xuefeng Xia; Shujun Cheng; Fan Yang; Jianjun Zhang; Jun Wang
Journal:  Am J Respir Crit Care Med       Date:  2021-11-15       Impact factor: 21.405

Review 6.  DNA Methylation in Lung Cancer: Mechanisms and Associations with Histological Subtypes, Molecular Alterations, and Major Epidemiological Factors.

Authors:  Phuc H Hoang; Maria Teresa Landi
Journal:  Cancers (Basel)       Date:  2022-02-15       Impact factor: 6.639

7.  Extracellular Vesicles Derived from Lung Cancer Cells Induce Transformation of Normal Fibroblasts into Lung Cancer-Associated Fibroblasts and Promote Metastasis of Lung Cancer by Delivering lncRNA HOTAIR.

Authors:  Xiaoxuan Zhang; Yan Zhang; Xin Qiu; Jing Cai; Zhenzhou Yang; Fangzhou Song
Journal:  Stem Cells Int       Date:  2022-10-11       Impact factor: 5.131

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.